Chemical Component Summary

Name2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)-1~{H}-pyrazol-3-one
Identifiers2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)-1~{H}-pyrazol-3-one
FormulaC13 H14 N8 O2
Molecular Weight314.303
TypeNON-POLYMER
Isomeric SMILESc1cn(nn1)C2=CNN(C2=O)c3cc(ncn3)N4CCOCC4
InChIInChI=1S/C13H14N8O2/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19/h1-2,7-9,17H,3-6H2
InChIKeyIJMBOKOTALXLKS-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count37
Chiral Atom Count0
Bond Count40
Aromatic Bond Count11

Drug Info: DrugBank

DrugBank IDDB15642 
NameMolidustat
Groups investigational
DescriptionMolidustat is under investigation in clinical trial NCT03350321 (A Study of Molidustat for Correction of Renal Anemia in Non-dialysis Subjects).
Synonyms
  • Molidustat
  • Molidustat sodium
CAS number1154028-82-6

Related Resource References

Resource NameReference
Pharos CHEMBL3646118
PubChem 59603622
ChEMBL CHEMBL3991036, CHEMBL3646118